Results
1 -
5 of
5RNA splicing and splicing regulator changes in prostate cancer pathology, Human Genetics Phase I study of the heat shock protein 90 (Hsp90) inhibitor onalespib (AT13387) administered on a daily for 2 consecutive days per week dosing schedule in patients with advanced solid tumors, Investigational New Drugs